Krishnendu Roy

Dr. Krishnendu (Krish) Roy is the Bruce and Bridgitt Evans Dean of Engineering and University Distinguished Professor at Vanderbilt University, with secondary appointments in Pathology, Microbiology, and Immunology, and Chemical and Biomolecular Engineering. Formerly, he served as a Regents Professor and Robert A. Milton Endowed Chair at Georgia Tech, and held leadership roles at The University of Texas at Austin. He directs major research centers like NSF ERC for Cell Manufacturing Technologies (CMaT) and the Marcus Center for Therapeutic Cell Characterization and Manufacturing (MC3M).

• Education:
  • Ph.D. in Biomedical Engineering, Johns Hopkins University
  • M.S., Biomedical Engineering, Boston University
  • B. Tech., Instrumentation Engineering, IIT Kharagpur

Research Focus: Develops biomaterial-based strategies for vaccine/immunotherapy delivery, microfluidics-based vascularized microenvironments for immune study, and high-throughput tools for manufacturing therapeutic immune cells. His work bridges engineering and medicine in regenerative therapies and cell manufacturing.

• Awards:
  • Clemson Award for Basic Research (2021)
  • NSF CAREER Award (2005)
  • Fellowships from AIMBE, BMES, and CRS

Leadership & Service: Co-chairs the National Academies Forum on Regenerative Medicine. Serves on editorial boards (Journal of Controlled Release, Journal of Immunology and Regenerative Medicine) and industry advisory boards. Former director of CMaT and MC3M.

Labs/Projects: Leads initiatives in cell manufacturing, immunotherapy delivery systems, and vascularized microfluidic platforms for disease modeling.